🇺🇸 FDA
Patent

US 9868736

Deubiquitinase inhibitors and methods for use of the same

granted A61PA61P1/04A61P1/16

Quick answer

US patent 9868736 (Deubiquitinase inhibitors and methods for use of the same) held by THE REGENTS OF THE UNIVERSITY OF MICHIGAN expires Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
Grant date
Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P1/04, A61P1/16, A61P11/00, A61P17/00